Arcturus Therapeutics Holdings Inc.
ARCT
$14.74
-$0.89-5.69%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 29.37M | 54.71M | 82.03M | 97.60M | 122.12M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.37M | 54.71M | 82.03M | 97.60M | 122.12M |
| Cost of Revenue | 86.78M | 98.85M | 112.21M | 131.52M | 147.39M |
| Gross Profit | -57.42M | -44.14M | -30.18M | -33.92M | -25.26M |
| SG&A Expenses | 44.88M | 44.23M | 46.08M | 44.43M | 47.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 131.66M | 143.08M | 158.29M | 175.95M | 194.70M |
| Operating Income | -102.30M | -88.37M | -76.26M | -78.35M | -72.57M |
| Income Before Tax | -93.28M | -78.67M | -65.78M | -66.71M | -60.38M |
| Income Tax Expenses | -4.00K | 0.00 | 0.00 | 0.00 | -217.00K |
| Earnings from Continuing Operations | -93.28 | -78.67 | -65.78 | -66.71 | -60.16 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -93.28M | -78.67M | -65.78M | -66.71M | -60.16M |
| EBIT | -102.30M | -88.37M | -76.26M | -78.35M | -72.57M |
| EBITDA | -99.55M | -85.48M | -73.24M | -75.19M | -69.26M |
| EPS Basic | -3.31 | -2.82 | -2.39 | -2.46 | -2.22 |
| Normalized Basic EPS | -2.07 | -1.76 | -1.49 | -1.54 | -1.40 |
| EPS Diluted | -3.31 | -2.82 | -2.39 | -2.46 | -2.22 |
| Normalized Diluted EPS | -2.07 | -1.76 | -1.49 | -1.54 | -1.40 |
| Average Basic Shares Outstanding | 112.14M | 110.85M | 109.54M | 108.42M | 108.30M |
| Average Diluted Shares Outstanding | 112.14M | 110.85M | 109.54M | 108.42M | 108.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |